These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8299095)

  • 1. The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
    Baltzer L; Kris MG; Tyson LB; Rigas JR; Pisters KM
    Cancer; 1994 Feb; 73(3):720-3. PubMed ID: 8299095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy.
    Ahn MJ; Lee JS; Lee KH; Suh C; Choi SS; Kim SH
    Am J Clin Oncol; 1994 Apr; 17(2):150-6. PubMed ID: 8141107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
    Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM; Province WS; Perrine GM; Kilgore JR
    Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
    Moreno I; Rosell R; Abad-Esteve A; Barnadas A; Carles J; Ribelles N
    Oncology; 1991; 48(5):397-402. PubMed ID: 1745488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam.
    Cunningham D; Dicato M; Verweij J; Crombez R; de Mulder P; du Bois A; Stewart A; Smyth J; Selby P; van Straelen D; Parideans R; McQuade B; McRae J
    Ann Oncol; 1996 Mar; 7(3):277-82. PubMed ID: 8740792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
    Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
    Stephens SH; Silvey VL; Wheeler RH
    Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Fanning J; Hilgers RD
    Obstet Gynecol; 1994 Apr; 83(4):601-4. PubMed ID: 8134073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
    J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
    O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
    Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
    Homesley HD; Hahne WF; McLees B; Heck K; Barrett RJ; Lentz SS; Woodlief L; Lovelace JV
    Am J Clin Oncol; 1993 Apr; 16(2):175-9. PubMed ID: 8452114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
    Mau YK; Li YT; Tsui MS; Tu FC; Hsu KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):116-20. PubMed ID: 1848133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.
    Kris MG; Tyson LB; Clark RA; Gralla RJ
    Cancer; 1992 Aug; 70(4 Suppl):1012-6. PubMed ID: 1386282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
    Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P
    Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
    Sands R; Roberts JT; Marsh M; Gill A
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):67. PubMed ID: 1531293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.